These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23651511)

  • 21. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
    Kanamoto A; Monaco AP; Maki T
    Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning.
    Blaha P; Bigenzahn S; Koporc Z; Sykes M; Muehlbacher F; Wekerle T
    Transplantation; 2005 Jul; 80(2):237-43. PubMed ID: 16041269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engraftment of quiescent progenitors and conversion to full chimerism after nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine.
    Lima B; Gleit ZL; Cameron AM; Germana S; Murphy MC; Consorti R; Chang Q; Down JD; LeGuern C; Sachs DH; Huang CA
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):571-82. PubMed ID: 14506659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.
    Yu P; Xiong S; He Q; Chu Y; Lu C; Ramlogan CA; Steel JC
    Immunology; 2009 Aug; 127(4):500-11. PubMed ID: 19604303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions.
    Eto M; Hackstein H; Kaneko K; Nomoto K; Thomson AW
    J Immunol; 2002 Sep; 169(5):2390-6. PubMed ID: 12193706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells.
    Liu L; Duan L; Gong M; Dai H; Gong Q; Zheng F; Tan Z; Wang C; Gong F; Fang M
    Cell Mol Immunol; 2011 Jan; 8(1):31-40. PubMed ID: 21200382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S
    Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.
    Nagasaki K; Obara H; Xiong A; Kambham N; Strober S; Esquivel CO; Millan MT
    Transplantation; 2007 Sep; 84(5):619-28. PubMed ID: 17876275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.
    Inverardi L; Linetsky E; Pileggi A; Molano RD; Serafini A; Paganelli G; Ricordi C
    Transplantation; 2004 Mar; 77(5):647-55. PubMed ID: 15021823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance.
    Chen JC; Chang ML; Huang SF; Chang PY; Muench MO; Fu RH; Ou LS; Kuo ML
    Cell Transplant; 2008; 17(5):495-506. PubMed ID: 18714669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
    Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G
    Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
    Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
    Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Chimeric Recipient Precursor T Cells Promote Cardiac Allograft Survival in Mice.
    Lu L; Zhang G; Li R; Zhao Z; Li W; Liu T; Fu W
    Transplant Proc; 2015 Dec; 47(10):2978-84. PubMed ID: 26707325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.